Financials in CAD. Standardized financial statements.
A compact view of how Optimind Pharma Corp. turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $118,368 | $122,959 | $170,113 | $99,690 | $0 | $0 | $0 | $0 | $0 | $0 |
| Revenue Growth? | -3.7% | -27.7% | +70.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $49,392 | $64,400 | $118,239 | $35,998 | $0 | $0 | $0 | $0 | $0 | $4,283.35 |
| Gross Profit? | $68,976 | $58,559 | $51,874 | $63,692 | $0 | $0 | $0 | $0 | $0 | -$4,283.35 |
| Gross Margin? | +58.3% | +47.6% | +30.5% | +63.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $334,180 | $889,830 | $1.37M | $161,324 | $79,414 | $40,094 | $213,677 | $483,397 | $114,641 | $114,630 |
| Operating Income? | -$215,812 | -$767,000 | -$864,000 | -$161,324 | -$79,410 | -$40,090 | -$214,000 | -$483,000 | -$115,000 | -$118,914 |
| EBITDA? | -$215,812 | -$1.29M | -$2.97M | -$131,713 | $176,538 | $110,173 | -$175,000 | $301,182 | -$115,000 | -$112,190 |
| Income Before Tax | -$215,812 | -$1.41M | -$3.09M | -$172,232 | $131,348 | -$25,175 | -$214,000 | $247,195 | -$147,000 | -$133,936 |
| Income Tax Expense | $0 | -$8,759 | -$8,849 | $0 | $0 | $0 | $0 | $0 | $0 | -$7,486.908 |
| Net Income? | -$215,812 | -$1.40M | -$3.08M | -$172,232 | $131,348 | -$25,175 | -$214,000 | $247,195 | -$147,000 | -$126,449 |
| EPS? | $-0.00 | $-0.01 | $-0.04 | $-0.03 | $0.04 | $-0.01 | $-0.06 | $0.09 | $-0.09 | $-0.04 |
| Diluted EPS? | $-0.00 | $-0.01 | $-0.04 | $-0.03 | $0.04 | $-0.01 | $-0.06 | $0.09 | $-0.09 | $-0.04 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality